Warning! GuruFocus detected
1 Severe warning sign
with DCAL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Dishman Carbogen Amics Ltd
ISIN : INE385W01011
Compare
Compare
Traded in other countries / regions
540701.India IPO Date
2004-04-22Description
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 6.53 | |||||
| Interest Coverage | 0.67 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.78 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10 | |||||
| 3-Year EBITDA Growth Rate | 2.3 | |||||
| 3-Year EPS without NRI Growth Rate | 0.3 | |||||
| 3-Year FCF Growth Rate | -18 | |||||
| 3-Year Book Growth Rate | -0.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.62 | |||||
| 9-Day RSI | 64.1 | |||||
| 14-Day RSI | 56.52 | |||||
| 3-1 Month Momentum % | -19.94 | |||||
| 6-1 Month Momentum % | 15.46 | |||||
| 12-1 Month Momentum % | 0.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.04 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 582 | |||||
| Days Sales Outstanding | 77.37 | |||||
| Days Payable | 145.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -4.21 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.6 | |||||
| Operating Margin % | 3.69 | |||||
| Net Margin % | -4.26 | |||||
| FCF Margin % | 3.13 | |||||
| ROE % | -1.92 | |||||
| ROA % | -1.13 | |||||
| ROIC % | 1.88 | |||||
| 3-Year ROIIC % | 0.97 | |||||
| ROC (Joel Greenblatt) % | 2.15 | |||||
| ROCE % | 1.11 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 46.34 | |||||
| Price-to-Owner-Earnings | 56.6 | |||||
| PS Ratio | 1.37 | |||||
| PB Ratio | 0.62 | |||||
| Price-to-Tangible-Book | 2.69 | |||||
| Price-to-Free-Cash-Flow | 44.06 | |||||
| Price-to-Operating-Cash-Flow | 9.27 | |||||
| EV-to-EBIT | 66.87 | |||||
| EV-to-EBITDA | 14.66 | |||||
| EV-to-Revenue | 2.18 | |||||
| EV-to-FCF | 70.28 | |||||
| Price-to-GF-Value | 1.32 | |||||
| Price-to-Projected-FCF | 0.81 | |||||
| Price-to-Median-PS-Value | 0.94 | |||||
| Earnings Yield (Greenblatt) % | 1.49 | |||||
| FCF Yield % | 2.27 | |||||
| Forward Rate of Return (Yacktman) % | -12.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dishman Carbogen Amics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 25,777.2 | ||
| EPS (TTM) (₹) | -7 | ||
| Beta | 1.47 | ||
| 3-Year Sharpe Ratio | 0.23 | ||
| 3-Year Sortino Ratio | 0.36 | ||
| Volatility % | 54 | ||
| 14-Day RSI | 56.52 | ||
| 14-Day ATR (₹) | 10.797682 | ||
| 20-Day SMA (₹) | 212.549 | ||
| 12-1 Month Momentum % | 0.14 | ||
| 52-Week Range (₹) | 133 - 307.98 | ||
| Shares Outstanding (Mil) | 156.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dishman Carbogen Amics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dishman Carbogen Amics Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dishman Carbogen Amics Ltd Frequently Asked Questions
What is Dishman Carbogen Amics Ltd(NSE:DCAL)'s stock price today?
The current price of NSE:DCAL is ₹226.81. The 52 week high of NSE:DCAL is ₹307.98 and 52 week low is ₹133.00.
When is next earnings date of Dishman Carbogen Amics Ltd(NSE:DCAL)?
The next earnings date of Dishman Carbogen Amics Ltd(NSE:DCAL) is 2025-05-30 Est..
Does Dishman Carbogen Amics Ltd(NSE:DCAL) pay dividends? If so, how much?
Dishman Carbogen Amics Ltd(NSE:DCAL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers